Jacobson Pharma Adjusts Valuation Amid Mixed Financial Indicators and Growth Challenges

Aug 26 2025 06:32 PM IST
share
Share Via
Jacobson Pharma Corp. has recently experienced a change in evaluation, reflecting a detailed analysis of its financial metrics and market standing. While the company shows solid returns on capital and equity, it faces challenges with long-term growth, highlighted by declining net sales and operating profit over recent years.
Jacobson Pharma Corp., a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in evaluation. This revision reflects a nuanced assessment of the company's financial metrics and market position.

The stock's P/E ratio stands at 10, indicating a valuation that is perceived as fair relative to its industry peers. The Price to Book Value is noted at 1.06, suggesting an attractive valuation. Additionally, the company has demonstrated a solid ROCE of 12.96% and an ROE of 11.15%, which are indicative of effective capital utilization and shareholder returns.

Despite some positive indicators, such as a notable pre-tax profit of HKD 215.14 million in March 2025 and a dividend yield of 4.87%, the company has faced challenges with long-term growth, as evidenced by a decline in net sales and operating profit over the past five years. The PEG ratio of 0.21 further highlights the company's valuation dynamics in relation to its growth prospects.

Overall, Jacobson Pharma Corp. continues to navigate a complex landscape, with its recent evaluation adjustment reflecting the interplay of various financial metrics and market conditions.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%